Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gabriela M. Maron"'
Autor:
Gabriela M. Maron, Diego R. Hijano, Rebecca Epperly, Yin Su, Li Tang, Randall T. Hayden, Swati Naik, Seth E. Karol, Stephen Gottschalk, Brandon M. Triplett, Aimee C. Talleur
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
CD19-specific chimeric antigen receptor (CAR) T cell therapy has changed the treatment paradigm for pediatric, adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, data on the associ
Externí odkaz:
https://doaj.org/article/1266e52cca5b45f0894172414eb1ca00
Autor:
Cara E. Morin, Morgan P. McBee, Lama Elbahlawan, Lindsay M. Griffin, Gabriela M. Maron, HaiThuy N. Nguyen, Akshay Sharma, Elizabeth J. Snyder, Jean Jeudy
Publikováno v:
Pediatric Radiology. 52:2017-2028
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80cc661eafaf622d8b772d1064a69cbd
https://doi.org/10.1007/s00247-022-05403-w
https://doi.org/10.1007/s00247-022-05403-w
Autor:
Cara E, Morin, Morgan P, McBee, Lama, Elbahlawan, Lindsay M, Griffin, Gabriela M, Maron, HaiThuy N, Nguyen, Akshay, Sharma, Elizabeth J, Snyder, Jean, Jeudy
Publikováno v:
Pediatric radiology. 52(10)
In this review, we summarize early pulmonary complications related to cancer therapy in children and highlight characteristic findings on imaging that should be familiar to a radiologist reviewing imaging from pediatric cancer patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::326c29435b64d235de99db487039dd53
https://pubmed.ncbi.nlm.nih.gov/35778572
https://pubmed.ncbi.nlm.nih.gov/35778572
Autor:
Joshua Wolf, Mark J Abzug, Brenda I Anosike, Surabhi B Vora, Alpana Waghmare, Paul K Sue, Rosemary M Olivero, Carlos R Oliveira, Scott H James, Theodore H Morton, Gabriela M Maron, Jennifer L Young, Rachel C Orscheln, Hayden T Schwenk, Laura L Bio, Zachary I Willis, Elizabeth C Lloyd, Adam L Hersh, Charles W Huskins, Vijaya L Soma, Adam J Ratner, Molly Hayes, Kevin Downes, Kathleen Chiotos, Steven P Grapentine, Rachel L Wattier, Gabriella S Lamb, Philip Zachariah, Mari M Nakamura
Publikováno v:
Journal of the Pediatric Infectious Diseases Society, vol 11, iss 5
Background Starting in November 2020, the US Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUAs) for multiple novel virus-neutralizing monoclonal antibody therapies, including bamlanivimab monotherapy (now revoked), baml
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5faa25d08ca067245f285e8472b21d4e
https://pubmed.ncbi.nlm.nih.gov/35107571
https://pubmed.ncbi.nlm.nih.gov/35107571